Solution Reagent Kit
Delivery Restriction
This product cannot be shipped to your selected delivery address/country. Purchase has been disabled.
Product Information
Product Description
The AmpliSeq for Illumina Immune Response Panel is a targeted resequencing research assay for quantitating expression of cancer biomarkers in 395 genes involved in tumor–immune system interactions.
Panel features
Relevant Gene Content - Targeted expression of 395 cancer biomarkers indicative of immunotherapy response
Fast, Streamlined Workflow - Prepare sequencing-ready libraries in a single day from as little as 1 ng of high quality RNA or 10 ng of formalin-fixed, paraffin-embedded (FFPE) RNA input samples
Accurate Data - Detect expression of genes involved in tumor-immune interactions
The Immune Response Panel is part of an integrated RNA-to-annotated variant solution that includes AmpliSeq for Illumina polymerase chain reaction (PCR)-based library preparation, Illumina sequencing by synthesis (SBS) next-generation sequencing (NGS) technology, and automated analysis.
Specifications
Assay time - 6 hours (library prep only; doesn't include library quantification, normalization, or pooling time)
Content specifications - 395 genes associated with immune response
Hands-on time -
Additional Information
- • Seller Company: Illumina, Inc.
- • Stock Status: In Stock
- • VAT Rate: %20
- • Delivery Status: Select address for delivery eligibility.
